Durvalumab vs Ramipril

Durvalumab vs Ramipril: Overview

This comparison examines the pharmacological differences between Durvalumab and Ramipril.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Ramipril: Prodrug converted to ramiprilat; ACE inhibitor.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Ramipril — 13-17 hours.

Chemical Properties

Molecular Formula: Ramipril — C23H32N2O5.

Molecular Weight: Ramipril — 416.5120 g/mol.

Type: Durvalumab — Antibody; Ramipril — Small molecule.